These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24787915)

  • 21. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
    Laurent C; Eddarkaoui S; Derisbourg M; Leboucher A; Demeyer D; Carrier S; Schneider M; Hamdane M; Müller CE; Buée L; Blum D
    Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice.
    Wu B; Wei Y; Wang Y; Su T; Zhou L; Liu Y; He R
    Oncotarget; 2015 Oct; 6(33):34128-42. PubMed ID: 26452037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model.
    Kim Y; Choi H; Lee W; Park H; Kam TI; Hong SH; Nah J; Jung S; Shin B; Lee H; Choi TY; Choo H; Kim KK; Choi SY; Kayed R; Jung YK
    Neurobiol Dis; 2016 Mar; 87():19-28. PubMed ID: 26704708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pesticides induce spatial memory deficits with synaptic impairments and an imbalanced tau phosphorylation in rats.
    Chen NN; Luo DJ; Yao XQ; Yu C; Wang Y; Wang Q; Wang JZ; Liu GP
    J Alzheimers Dis; 2012; 30(3):585-94. PubMed ID: 22451311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C.
    Jiang X; Tian Q; Wang Y; Zhou XW; Xie JZ; Wang JZ; Zhu LQ
    J Neurochem; 2011 Sep; 118(5):864-78. PubMed ID: 21689104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation.
    Zhao HH; Di J; Liu WS; Liu HL; Lai H; Lü YL
    Behav Brain Res; 2013 Mar; 241():228-34. PubMed ID: 23219964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease.
    Capsoni S; Carlo AS; Vignone D; Amato G; Criscuolo C; Willnow TE; Cattaneo A
    J Alzheimers Dis; 2013; 33(2):357-71. PubMed ID: 22986780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose total-body carbon-ion irradiations induce early transcriptional alteration without late Alzheimer's disease-like pathogenesis and memory impairment in mice.
    Wang B; Tanaka K; Ji B; Ono M; Fang Y; Ninomiya Y; Maruyama K; Izumi-Nakajima N; Begum N; Higuchi M; Fujimori A; Uehara Y; Nakajima T; Suhara T; Nenoi M
    J Neurosci Res; 2014 Jul; 92(7):915-26. PubMed ID: 24936619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Green tea polyphenols protect against okadaic acid-induced acute learning and memory impairments in rats.
    Li H; Wu X; Wu Q; Gong D; Shi M; Guan L; Zhang J; Liu J; Yuan B; Han G; Zou Y
    Nutrition; 2014 Mar; 30(3):337-42. PubMed ID: 24484683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
    Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
    Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo.
    Bitner RS; Nikkel AL; Markosyan S; Otte S; Puttfarcken P; Gopalakrishnan M
    Brain Res; 2009 Apr; 1265():65-74. PubMed ID: 19230830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of molecular mechanisms of learning and memory impairment in neonatal rats post intrauterine distress via the pathway of Tau protein hyperphosphorylation.
    Wang XS; Huang H
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2787-2800. PubMed ID: 29771431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice.
    Kanno T; Tsuchiya A; Nishizaki T
    Behav Brain Res; 2014 Nov; 274():302-6. PubMed ID: 25172181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperphosphorylation results in tau dysfunction in DNA folding and protection.
    Lu Y; He HJ; Zhou J; Miao JY; Lu J; He YG; Pan R; Wei Y; Liu Y; He RQ
    J Alzheimers Dis; 2013; 37(3):551-63. PubMed ID: 24064506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.